International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies.

dc.contributor.authorAgmon-Levin, Nancy
dc.contributor.authorDamoiseaux, Jan
dc.contributor.authorKallenberg, Cees G. M.
dc.contributor.authorSack, Ulrich
dc.contributor.authorWitte, Torsten
dc.contributor.authorHerold, Manfred
dc.contributor.authorBossuyt, Xavier
dc.contributor.authorMusset, Lucille
dc.contributor.authorCervera i Segura, Ricard, 1960-
dc.contributor.authorPlaza-López, Aresio
dc.contributor.authorDias, Carlos
dc.contributor.authorSousa, Maria José
dc.contributor.authorRadice, Antonella
dc.contributor.authorEriksson, Catharina
dc.contributor.authorHultgren, Olof
dc.contributor.authorViander, Markku
dc.contributor.authorKhamashta, Munther A.
dc.contributor.authorRegenass, Stephan
dc.contributor.authorCoelho Andrade, Luis Eduardo
dc.contributor.authorWiik, Allan
dc.contributor.authorTincani, Angela
dc.contributor.authorRönnelid, Johan
dc.contributor.authorBloch, Donald B.
dc.contributor.authorFritzler, Marvin J.
dc.contributor.authorChan, Edward K.L.
dc.contributor.authorGarcía de la Torre, I.
dc.contributor.authorKonstantinov, Konstatin N.
dc.contributor.authorLahita, Robert
dc.contributor.authorWilson, Merlin
dc.contributor.authorVainio, Olli
dc.contributor.authorFabien, Nicole
dc.contributor.authorSinico, Renato Alberto
dc.contributor.authorMeroni, Pierluigi
dc.contributor.authorSheoenfeld, Yehuda
dc.date.accessioned2018-04-20T07:22:05Z
dc.date.available2018-04-20T07:22:05Z
dc.date.issued2013-10-13
dc.date.updated2018-04-20T07:22:05Z
dc.description.abstractAnti-nuclear antibodies (ANA) are fundamental for the diagnosis of autoimmune diseases, and have been determined by indirect immunofluorescence assay (IIFA) for decades. As the demand for ANA testing increased, alternative techniques were developed challenging the classic IIFA. These alternative platforms differ in their antigen profiles, sensitivity and specificity, raising uncertainties regarding standardisation and interpretation of incongruent results. Therefore, an international group of experts has created recommendations for ANA testing by different methods. Two groups of experts participated in this initiative. The European autoimmunity standardization initiative representing 15 European countries and the International Union of Immunologic Societies/World Health Organization/Arthritis Foundation/Centers for Disease Control and Prevention autoantibody standardising committee. A three-step process followed by a Delphi exercise with closed voting was applied. Twenty-five recommendations for determining ANA (1-13), anti-double stranded DNA antibodies (14-18), specific antibodies (19-23) and validation of methods (24-25) were created. Significant differences between experts were observed regarding recommendations 24-25 (p<0.03). Here, we formulated recommendations for the assessment and interpretation of ANA and associated antibodies. Notably, the roles of IIFA as a reference method, and the importance of defining nuclear and cytoplasmic staining, were emphasised, while the need to incorporate alternative automated methods was acknowledged. Various approaches to overcome discrepancies between methods were suggested of which an improved bench-to-bedside communication is of the utmost importance. These recommendations are based on current knowledge and can enable harmonisation of local algorithms for testing and evaluation of ANA and related autoantibodies. Last but not least, new more appropriate terminologies have been suggested.
dc.format.extent8 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec643127
dc.identifier.issn0003-4967
dc.identifier.pmid24126457
dc.identifier.urihttps://hdl.handle.net/2445/121728
dc.language.isoeng
dc.publisherBMJ Publishing Group
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1136/annrheumdis-2013-203863
dc.relation.ispartofAnnals of the Rheumatic Diseases, 2014, vol. 73, num. 1, p. 17-23
dc.relation.urihttps://doi.org/10.1136/annrheumdis-2013-203863
dc.rights(c) BMJ Publishing Group, 2014
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (Medicina)
dc.subject.classificationAntígens
dc.subject.classificationMalalties autoimmunitàries
dc.subject.classificationLupus eritematós
dc.subject.classificationSíndrome de Sjögren
dc.subject.otherAntigens
dc.subject.otherAutoimmune diseases
dc.subject.otherLupus erythematosus
dc.subject.otherSjogren's syndrome
dc.titleInternational recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies.
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
643127.pdf
Mida:
139.48 KB
Format:
Adobe Portable Document Format